Michael F. Roman - Mar 31, 2023 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
Director
Signature
/s/ Michael F. Roman by Jessica H. Paik, Attorney-in-Fact
Stock symbol
ABT
Transactions as of
Mar 31, 2023
Transactions value $
$32,910
Form type
4
Date filed
4/4/2023, 07:29 PM
Previous filing
Feb 21, 2023
Next filing
May 2, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABT Stock Equivalent Units Award $32.9K +325 +16.58% $101.26 2.29K Mar 31, 2023 Common Shares 325 Direct F1, F2

Explanation of Responses:

Id Content
F1 Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.
F2 Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.